Vident Investment Advisory’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-20,526
| Closed | -$1.84M | – | 989 |
|
|
2018
Q1 | $1.84M | Buy |
20,526
+5,483
| +36% | +$490K | 0.07% | 321 |
|
|
2017
Q4 | $1.27M | Buy |
15,043
+4,078
| +37% | +$343K | 0.06% | 338 |
|
|
2017
Q3 | $1.27M | Buy |
10,965
+333
| +3% | +$38.4K | 0.07% | 335 |
|
|
2017
Q2 | $1.24M | Buy |
10,632
+4,973
| +88% | +$581K | 0.1% | 299 |
|
|
2017
Q1 | $698K | Buy |
5,659
+943
| +20% | +$116K | 0.07% | 327 |
|
|
2016
Q4 | $642K | Sell |
4,716
-607
| -11% | -$82.6K | 0.08% | 324 |
|
|
2016
Q3 | $1.06M | Sell |
5,323
-84
| -2% | -$16.7K | 0.14% | 270 |
|
|
2016
Q2 | $701K | Sell |
5,407
-2,167
| -29% | -$281K | 0.1% | 317 |
|
|
2016
Q1 | $708 | Buy |
7,574
+3,534
| +87% | +$330 | 0.04% | 362 |
|
|
2015
Q4 | $819K | Buy |
+4,040
| New | +$819K | 0.1% | 328 |
|